Main Article Content
Background and Objective: Pain is a common complaint in knee osteoarthritis (OA) and the main cause of functional disabilities among middleâ€‘aged and older persons. The conventional treatments are medications, administered in longâ€‘term and are costly with significant side effects. Therefore, it is necessary to develop new efficient therapeutic approaches part icularly those ones that allow the patients to continue their work. The present study aimed to comparatively investigate the pain relieving efficacy of intraâ€‘articular injection of methylprednisolone alone and combined ketamineâ€‘methylprednisolone in patients with knee OA.
Materials and Methods: This is a doubleâ€‘blind clinical trial conducted on patients with knee OA. Seventy patients were randomly divided into two treatment groups (each group 35 cases aged 40â€‘73 years old) of control and case groups. The control group received 40 mg methylprednisolone and 1 ml of distilled water and the case group received 40 mg of methylprednisolone along with ketamine (0.5 mg/kg) intraâ€‘articularly. The pain perceived by the patients was assessed using a visual analog scale (VAS) (at threeâ€‘time points: Before injection, 1 month, and 3 months after injection). The amount of pain reduction was compared preâ€‘ and postâ€‘injection in each group and between the two groups. Results: The pain reduction in the control and case groups was the same at the 1st month. The pain VAS score in the control group at the 3 month followâ€‘up showed gradually increased. Conclusion: The VAS pain score showed a higher level of stability in the reduction of pain intensity in case group and these people experienced the reduction in the severity of pain for a longer time.
This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.